Job Trends
Labor Market Reports
BioSpace’s Q3 2025 U.S. Life Sciences Job Market Report reveals a turbulent quarter for biopharma hiring, with record declines in job postings, rising layoffs, and cautious employer sentiment shaping the industry’s employment landscape.
BioSpace data show biopharma professionals faced increased competition for fewer employment opportunities during the second quarter of 2025, with increased pressure from further layoffs.
Establishing trust through thought leadership is no longer optional in today’s cautious biopharma market. Learn how strategic insights and targeted outreach can turn awareness into high-converting leads.
Now Hiring
Looking for a biopharma job? Check out the BioSpace list of 12 top companies hiring life sciences professionals like you.
Looking for a biopharma job in New York? Check out the BioSpace list of eight companies hiring life sciences professionals like you.
Of the 25 companies receiving tax incentives in Massachusetts, 23 will add jobs outside of Boston and Cambridge. Medtronic, which is receiving the largest award, will create 220 roles in Billerica. Other recipients include AbbVie, Dyne Therapeutics and Viridian Therapeutics.
Career Advice
Clarity on employment terms is essential to protect careers. In this column, Kaye/Bassman’s Michael Pietrack speaks to employment attorney Howard Matalon, JD, partner at OlenderFeldman, on how to evaluate the fine print of an employment agreement.
THE LATEST
Mako Medical is lowering pharmacy costs with a new mobile app aimed at pricing transparency and access to lower-cost meds. This new model uses cost-plus pricing — not retail rates.
Using artificial intelligence and machine learning, the collaboration will focus on delivering new technology to help enable faster delivery of medical therapies to the biotech and pharma industries
There’s a growing demand for life sciences professionals in Massachusetts, but a new report indicates that the home-grown talent pipeline is not adequate enough to meet the growing demands in the Bay State.
It was a busy week for biotech quarterly and annual reports. Here’s a look at some of the top stories including Bristol-Myers Squibb, AbbVie, GSK, Merck and more.
3DR Labs will employ Resonance Health’s FerriSmart® software to analyze liver iron concentrations from MRIs and provide summary reports
A University of Houston engineering professor is examining the life cycle of stubborn, drug-resistant persister cells in recurrent infections to find a way to destroy them.
The biotech Hotbed known as Pharm Country, which includes New Jersey, Connecticut, New York Pennsylvania and Rhode Island, is an area of rapid growth and change.
The focus is on containment, although a number of organizations and companies are beginning work on vaccines.
It was another busy week for clinical trial updates. Here’s a look.
Kansas City, KS- SEKISUI XenoTech announces the promotion of Dr. Darren Warren, PhD to President and Chief Executive Officer.